❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️ ❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️‍🩹

More than 700,000 university graduates are claiming benefits saying they're too sick to work. Analysis by the Centre for Social Justice has found there has been a 46% rise in claimants since 2019, with one in three saying health problems are the reason they can't get a job. /1

West China Hospital followed 22 people for a year and found persistent retinal damage after COVID-19. Even without vision symptoms, scans showed thinning of nerve layers and disrupted blood flow, suggesting long-term eye effects from the virus. https://t.co/ylRUWflkMy

The forced intimacy of chronic illness. This is a really important point that HCWs- and everyone for that matter- need to understand 1/

Time to get this #LongCOVID trial utilizing @Invivyd’s newest monoclonal, VYD-2311 out ASAP. I called on @NIH RECOVER-TLC to take this seriously last year and we have seen no movement on this obvious and innovative target. This can’t wait any longer. https://t.co/jOZeQ0HMOO

The Shingles vaccine is linked to slowing biological aging and reducing inflammation https://t.co/nTUU1Fs8de

I want to do that scan on my #dysautonomia, #MECFS and #LongCOVID patients. I am fairly positive that abnormalities in the venous system would be identified in a large subset of patients. Give me a grant to study this! 🧠💲

https://t.co/vpqFwOnvD0

A PERSONAL ADVICE: 🫀You suspect possible HEART issues after your COVID-19? Make an appointment with your GP or cardiologist, and consider starting the conversation like this: ➡️"I've developed new symptoms such as [e.g., rapid heartbeat, dizziness, chest discomfort, or

That we're in a place, at a time, when someone has to write this headline, this article — it's almost unfathomable. Please do read @KrutikaKuppalli 's take.

We receive understandable questions and concerns from people living with Long Covid about how vaccination may impact their symptoms. There’s real fear that another Covid infection can worsen their systems and cause setbacks. At the same time, there’s also concern that

UCLA-led study finds SARS-CoV-2 fragments can persist and form pore-making peptides that target immune cells by shape. This may help explain long-lasting pDC and T cell loss seen in long COVID. https://t.co/a2RfyiFELd

As we begin the New Year 2026, I have great hopes for research to advance our understanding of #PAIS. This requires determination and collaboration across fields, sectors, and society. So grateful to work with many of you to find and eliminate root causes of #LongCOVID #MECFS 🙏🏼

Sustained illness burden over time among Australians with ME/chronic fatigue syndrome https://t.co/1JzuUs3K4K "These consistent, profound impairments emphasise the need for improved access to disability & social support services for pwME/CFS in Australia through policy reform"

Hi @jonstewart I am #oneofthetwo here in Australia because I work in general practice and want to continue to provide a safe #healthcare environment for our patients and clinic staff, and I understand the potentially devastating impacts of long COVID.

Hi @jonstewart, I’m #oneofthetwo because I run the Long COVID clinic at Mass General Brigham where I’ve talked to thousands and thousands of people who have had their lives devastated by COVID 19. The only way to prevent Long COVID is to not contract COVID. Masking is STILL a

Hi @Jonstewart! We met backstage @TheDailyShow before #LongCOVID disabled & made me #OneOfTheTwo. We mask because we have no #LongCOVID tests, treatments or cure. You can make this a breakthrough moment: dedicate a @weeklyshowpod to our fight for US research funding. @LCCampaign

No.5 on our list of influential PolyBio moments of 2025: the beginning of a biomarker project for Alzheimer’s patients with a chronic gut CMV-driven disease pathogenesis (25-45% of patients). If validated, the blood-based biomarker will help set up an RCT of Valacyclovir for this

Australian Influenza update: The unusual second wave of influenza is continuing in most states of Australia, driven by the clade K (H3N2 clade 2a.3a.1, subclade K) – "Kangaroo variant". #Influenza #Australia 🧵

A recent scientific paper included an antigenic map, comparing the immune status of individuals vaccinated with a range of vaccines "… vaccinated sera", against a collection of significant variants "Virus …". The map was very informative, so I built a quick dataviz project. 🧵

The NHMRC yesterday announced final allocations for the year. The 2025 success rate for Ideas grants was 10%, Investigator grants 13%, and Clinical Trials 9%. Australia's total spend on healthcare and technology innovation in medicine and biotech from the Medical Research